Analytical platform evaluation for quantification of ERG in prostate cancer using protein and mRNA detection methods

BACKGROUND: The established methods for detecting prostate cancer (CaP) are based on tests using PSA (blood), PCA3 (urine), and AMACR (tissue) as biomarkers in patient samples. The demonstration of ERG oncoprotein overexpression due to gene fusion in CaP has thus provided ERG as an additional biomar...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Jintang, Schepmoes, Athena A, Shi, Tujin, Wu, Chaochao, Fillmore, Thomas L, Gao, Yuqian, Smith, Richard D, Qian, Wei-Jun, Rodland, Karin D, Liu, Tao, Camp, David G, Rastogi, Anshu, Tan, Shyh-Han, Yan, Wusheng, Mohamed, Ahmed A, Huang, Wei, Banerjee, Sreedatta, Kagan, Jacob, Srivastava, Sudhir, McLeod, David G, Srivastava, Shiv, Petrovics, Gyorgy, Dobi, Albert, Srinivasan, Alagarsamy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Methodology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4342100/
https://www.ncbi.nlm.nih.gov/pubmed/25889691
http://dx.doi.org/10.1186/s12967-015-0418-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4342100/
https://www.ncbi.nlm.nih.gov/pubmed/25889691
http://dx.doi.org/10.1186/s12967-015-0418-z

Ejemplares similares